Simulations Plus Inc. (SLP)
NASDAQ: SLP
· Real-Time Price · USD
28.99
-0.02 (-0.07%)
At close: May 07, 2025, 3:59 PM
28.99
0.00%
After-hours: May 07, 2025, 04:05 PM EDT
-0.07% (1D)
Bid | 26.86 |
Market Cap | 583.02M |
Revenue (ttm) | 78.56M |
Net Income (ttm) | 7.22M |
EPS (ttm) | 0.36 |
PE Ratio (ttm) | 80.53 |
Forward PE | 22.99 |
Analyst | Buy |
Ask | 31.32 |
Volume | 359,544 |
Avg. Volume (20D) | 292,843 |
Open | 29.19 |
Previous Close | 29.01 |
Day's Range | 27.88 - 29.41 |
52-Week Range | 23.01 - 51.22 |
Beta | 1.10 |
Analyst Forecast
According to 0 analyst ratings, the average rating for SLP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+26.85%
Shares of healthcare technology stocks are trading...
Unlock content with
Pro Subscription
3 weeks ago
+0.74%
Simulations Plus shares are trading higher. The stock may be moving up after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.

1 month ago · seekingalpha.com
Simulations Plus: I See Promising Growth, But I'm Staying NeutralSimulations Plus, Inc. excels with its AI-driven biosimulation platforms, aiding drug development, but faces challenges with margin erosion and cash flow pressures. Despite strong revenue growth and p...

1 month ago · businesswire.com
Simulations Plus Reports Second Quarter Fiscal 2025 Financial ResultsRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intel...